Do gabapentin or pregabalin directly modulate the µ receptor?
Background Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in...
Main Authors: | Preeti Manandhar, Bridin Patricia Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
PeerJ Inc.
2021-04-01
|
Serier: | PeerJ |
Fag: | |
Online adgang: | https://peerj.com/articles/11175.pdf |
Lignende værker
-
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
af: Emily J.R. Carter, et al.
Udgivet: (2024-11-01) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
af: Qin Xiang Ng, et al.
Udgivet: (2021-08-01) -
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
af: Telmo Martínez, et al.
Udgivet: (2023-11-01) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
af: Payal H. Desai, PharmD, BCCCP, et al.
Udgivet: (2021-07-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
af: Paolo Marchettini, et al.
Udgivet: (2005-05-01)